Sort   by:  
 Page size 
UnknownLong-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study.
Not available
S-EPMC6031112 | biostudies-literature
UnknownPharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria.
Not available
S-EPMC8504851 | biostudies-literature
UnknownPegvaliase for the treatment of phenylketonuria: Final results of a long-term phase 3 clinical trial program.
Not available
S-EPMC11061743 | biostudies-literature
UnknownEvidence- and consensus-based recommendations for the use of pegvaliase in adults with phenylketonuria.
Not available
S-EPMC6752676 | biostudies-literature
Sort   by:  
 Page size